ZWZi-Jun Wang

Zi-Jun Wang

*This is an algorithmically generated author record based on publicly available information.

Zi-Jun Wang has a total of 35 co-authors. Here are the top co-authors by number of shared publications:

  • Aiyi Liu

    Department of Physiology and Biophysics, School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, NY 14203, USA

    1 shared publication
  • Benjamin Rein

    Department of Physiology and Biophysics, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, USA

    1 shared publication
  • Bin Yu

    Department of pharmacology, Peking University, School of Basic Medical Science, 38 Xueyuan Road, Beijing, 100191, China

    1 shared publication
  • David M. Dietz

    Department of Pharmacology and Toxicology, University at Buffalo, Buffalo, NY

    1 shared publication
  • Guang Yang

    Department of pharmacology, Peking University, School of Basic Medical Science, 38 Xueyuan Road, Beijing, 100191, China

    1 shared publication
  • Hao Sun

    Wolfson Institute for Biomedical Research, UCL Division of Medicine, University College London, London, UK

    1 shared publication

Latest Publications

  • Open Access

    Enhanced degradation of methylene blue dye using hydrothermally synthesized Nickel-doped Strontium oxide catalysts

    by Jehangir Shah, Hao Sun, Zijun Qiao, Talha Sharif, Misbah Gul

    Methylene blue is an organic contaminant that is produced by the plastic, textile, and dye industries. Many studies have been undertaken to investigate the cleanup of methylene blue from industrial effluents. SrO nanoparticles are now being utilized to remove methylene blue colours from water. We used a hydrothermal technique to create strontium oxide nanoparticles for photocatalytic MB breakdown under light conditions. To enhance the solar light activity and avoid charge recombination, we employed a hydrothermal technique to add Ni as a dopant in strontium oxide nanoparticles. Strong base NaOH, nickel nitrate, and strontium nitrate were used as precursors. The nanoparticles were crushed into powder and calcined at 450 °C in a muffle furnace to produce SrO and Ni-doped SrO nanoparticles. The nanoparticles were analyzed using several analytical methods to determine their morphological and structural properties. At 309, 312, and 317 nm, UV-Vis spectroscopy showed absorbance values of SrO doped with varied nickel concentrations. The Ni–O stretching peak was identified in the FTIR analysis of strontium oxide nanoparticles at 402 cm-1 and 581 cm-1, whereas the Sr–O bond gave a signal at 854.84 cm-1. SEM images of Ni-doped SrO nanoparticles were created at various magnifications. The nanostrips are hexagonal and cylindrical. Sherrer's equation was used to compute the average crystalline structure, which showed that the diameters of pure and Ni-doped SrO (2 percent, 3 percent, and 4 percent) nanoparticles were 45.54 nm, 36.14 nm, 42.93 nm, and 41.21 nm, respectively. According to the EDX examination, the relative concentration of Ni-doped SrO is about 72 percent Sr and oxygen, with around 1.34 percent Ni. The resulting sample was tested for photocatalytic degradation of organic pollutants in aqueous solution, such as methylene blue, and the completion of the reaction was monitored using UV-visible spectroscopy to measure the % photocatalytic degradation during light illumination. According to the UV-visible spectra, 90% of the dye was effectively destroyed.


  • Open Access

    DNA Methyltransferase 3A Is Involved in the Sustained Effects of Chronic Stress on Synaptic Functions and Behaviors

    by Jing Wei, Jia Cheng, Nicholas J Waddell, Zi-Jun Wang, Xiaodong Pang, Qing Cao, Aiyi Liu, Javed M Chitaman, Kristen Abreu, Rahul Singh Jasrotia, et al.

    Emerging evidence suggests that epigenetic mechanisms regulate aberrant gene transcription in stress-associated mental disorders. However, it remains to be elucidated about the role of DNA methylation and its catalyzing enzymes, DNA methyltransferases (DNMTs), in this process. Here, we found that male rats exposed to chronic (2-week) unpredictable stress exhibited a substantial reduction of Dnmt3a after stress cessation in the prefrontal cortex (PFC), a key target region of stress. Treatment of unstressed control rats with DNMT inhibitors recapitulated the effect of chronic unpredictable stress on decreased AMPAR expression and function in PFC. In contrast, overexpression of Dnmt3a in PFC of stressed animals prevented the loss of glutamatergic responses. Moreover, the stress-induced behavioral abnormalities, including the impaired recognition memory, heightened aggression, and hyperlocomotion, were partially attenuated by Dnmt3a expression in PFC of stressed animals. Finally, we found that there were genome-wide DNA methylation changes and transcriptome alterations in PFC of stressed rats, both of which were enriched at several neural pathways, including glutamatergic synapse and microtubule-associated protein kinase signaling. These results have therefore recognized the potential role of DNA epigenetic modification in stress-induced disturbance of synaptic functions and cognitive and emotional processes.


  • Diminished social interaction incentive contributes to social deficits in mouse models of autism spectrum disorder

    by Benjamin Rein, Zhen Yan, Zi‐Jun Wang

    One of the core symptoms of autism spectrum disorder (ASD) is impaired social interaction. Currently, no pharmacotherapies exist for this symptom due to complex biological underpinnings and distinct genetic models which fail to represent the broad disease spectrum. One convincing hypothesis explaining social deficits in human ASD patients is amotivation, however it is unknown whether mouse models of ASD represent this condition. Here we used two highly trusted ASD mouse models (male Shank3‐deficient [Shank3+/ΔC] mice modeling the monogenic etiology of ASD, and inbred BTBR mice [both male and female] modeling the idiopathic and highly polygenic pathology for ASD) to evaluate the level of motivation to engage in a social interaction. In the behavioral paradigms utilized, a social stimulus was placed in the open arm of the elevated plus maze (EPM), or the light compartment of the light‐dark box (LDB). To engage in a social interaction, mice were thus required to endure innately aversive conditions (open areas, height, and/or light). In the modified EPM paradigm, both Shank3+/ΔC and BTBR mice demonstrated decreased open‐arm engagement with a social stimulus but not a novel object, suggesting reduced incentive to engage in a social interaction in these models. However, these deficits were not expressed under the less severe aversive pressures of the LDB. Collectively, we show that ASD mouse models exhibit diminished social interaction incentive, and provide a new investigation strategy facilitating the study of the neurobiological mechanisms underlying social reward and motivation deficits in neuropsychiatric disorders.


  • The Molecular Basis of Insomnia: Implication for Therapeutic Approaches

    by Zi‐Jun Wang, Jian‐Feng Liu

    Preclinical Research Insomnia is one of the most common sleep disorders that is characterized by difficulty in sleep initiation, sleep maintenance, and/or poor sleep quality. Treatment for insomnia includes both pharmacological and non‐pharmacological interventions. Recently, the development of pharmacological treatment for insomnia has been prompted by the understanding of the molecular neurobiology of sleep‐wake regulation. For pharmacological treatment, benzodiazepines that target GABAergic system are the most widely used hypnotics. Besides GABA, the hypocretin/orexin system, and the hypothalamic–pituitary–adrenal (HPA) axis are involved in sleep‐wake regulation and may also play important role in the pathogenesis of insomnia. Genetic studies have revealed the critical role of several important genes related to the above‐mentioned systems in the regulation and function of sleep, suggesting the genetic/epigenetic factors could also contribute to the development and regulation of insomnia. Non‐pharmacological interventions include cognitive behavioral therapy for insomnia (CBT‐I) that is an effective insomnia treatment with less risk and side effects of drug therapy. Here the current treatments for insomnia based on the molecular mechanisms underlying sleep‐wake regulation, were reviewed and some newer targets that may be beneficial in the development of new treatments for insomnia were discussed. Drug Dev Res 77 : 427–436, 2016.


  • Open Access

    Ca2+ in the dorsal raphe nucleus promotes wakefulness via endogenous sleep-wake regulating pathway in the rats

    by Su-Ying Cui, Sheng-Jie Li, Xiang-Yu Cui, Xue-Qiong Zhang, Bin Yu, Yuan-Li Huang, Qing Cao, Ya-Ping Xu, Guang Yang, Hui Ding, et al.

    Serotonergic neurons in the dorsal raphe nucleus (DRN) are involved in the control of sleep-wake states. Our previous studies have indicated that calcium (Ca2+) modulation in the DRN plays an important role in rapid-eye-movement sleep (REMS) and non-REMS (NREMS) regulation during pentobarbital hypnosis. The present study investigated the effects of Ca2+ in the DRN on sleep-wake regulation and the related neuronal mechanism in freely moving rats. Our results showed that microinjection of CaCl2 (25 or 50 nmol) in the DRN promoted wakefulness and suppressed NREMS including slow wave sleep and REMS in freely moving rats. Application of CaCl2 (25 or 50 nmol) in the DRN significantly increased serotonin in the DRN and hypothalamus, and noradrenaline in the locus coeruleus and hypothalamus. Immunohistochemistry study indicated that application of CaCl2 (25 or 50 nmol) in the DRN significantly increased c-Fos expression ratio in wake-promoting neurons including serotonergic neurons in the DRN, noradrenergic neurons in the locus coeruleus, and orxinergic neurons in the perifornical nucleus, but decreased c-Fos expression ratio of GABAergic sleep-promoting neurons in the ventrolateral preoptic nucleus. These results suggest that Ca2+ in the DRN exert arousal effects via up-regulating serotonergic functions in the endogenous sleep-wake regulating pathways.